What is difference between type 1 respiratory failure and type 2 respiratory failure
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
I now have comprehensive information from multiple authoritative textbooks. Here is the full answer:
Type 1 vs Type 2 Respiratory Failure
Definitions
| Feature | Type 1 (Hypoxaemic) | Type 2 (Hypercapnic / Ventilatory) |
|---|---|---|
| PaO2 | Low (<60 mmHg) | Low (<60 mmHg) |
| PaCO2 | Normal or low | Elevated (>45 mmHg) |
| pH | Normal or high (resp. alkalosis) | Low (<7.35, respiratory acidosis) |
| Core problem | Failure of oxygenation | Failure of ventilation |
| A-a gradient | Elevated (usually) | Normal (in pure hypoventilation) |
- Tintinalli's Emergency Medicine states it simply: "Type 1 respiratory failure has hypoxia without hypercapnia. Type 2 respiratory failure has hypoxia with hypercapnia."
- The Washington Manual of Medical Therapeutics defines Type 2 as "acute elevation of CO2 (PaCO2 >45 mmHg), producing a respiratory acidosis (pH <7.35)."
Mechanisms
Type 1 - Five causes of hypoxaemia (all raise the A-a gradient except the last two):
- V/Q mismatch - perfusion/ventilation imbalance (e.g. pneumonia, pulmonary embolism, COPD, pulmonary oedema). Responds to supplemental O2.
- Shunt - venous blood bypasses oxygenation entirely (e.g. atelectasis, ARDS, intracardiac defects). Does NOT respond to supplemental O2.
- Diffusion abnormality - gas equilibration across a thickened interstitium takes longer than RBC transit time (e.g. interstitial lung disease). Worsens on exercise.
- Hypoventilation - decreased minute ventilation raises PaCO2 and displaces O2; A-a gradient is normal. Responds to supplemental O2.
- Low inspired oxygen - high altitude; A-a gradient is normal. Responds to supplemental O2.
Type 2 - Failure of one component of the respiratory pump:
- Central nervous system - impaired respiratory drive ("won't breathe"): opioid/sedative overdose, CNS infection, central apnoea, metabolic alkalosis.
- Anterior horn cells / peripheral nerves / muscles - neuromuscular failure, decreased tidal volume ("can't breathe"): Guillain-Barré syndrome, myasthenia gravis, ALS, muscular dystrophies.
- Thoracic cage - mechanical restriction of tidal volume: kyphoscoliosis, morbid obesity, pleural effusions, abdominal distension.
- Airway or lung parenchyma - increased dead space: COPD (most common), severe asthma, severe ARDS.
- Hypermetabolic states - increased CO2 production overwhelming ventilatory capacity: sepsis, seizures, thyrotoxicosis.
Common Causes at a Glance
| Type 1 | Type 2 |
|---|---|
| Pneumonia | COPD exacerbation |
| Pulmonary embolism | Acute severe asthma |
| ARDS | Opioid/sedative overdose |
| Cardiogenic pulmonary oedema | Guillain-Barré syndrome |
| Interstitial lung disease | Myasthenia gravis |
| Pneumothorax | Obesity hypoventilation syndrome |
| Pulmonary haemorrhage | Kyphoscoliosis |
Management Principles
| Type 1 | Type 2 | |
|---|---|---|
| Goal | Optimise oxygenation | Correct ventilation AND oxygenation |
| Supplemental O2 | Usually effective (except pure shunt) | Useful, but must be cautious in COPD (can worsen hypercapnia by reversing hypoxic pulmonary vasoconstriction) |
| NIV (BiPAP) | CPAP for cardiogenic oedema/ARDS | BiPAP - supports both inspiratory and expiratory phases; first-line in COPD exacerbation |
| Invasive ventilation | If oxygenation fails despite maximal NIV | If ventilatory drive is lost or NIV fails |
| Specific treatment | Treat underlying cause (antibiotics, diuretics, thrombolytics) | Reverse precipitant (e.g. naloxone for opioids, treat infection, neostigmine for MG) |
Additional Classification (Washington Manual)
Some sources recognise additional subtypes:
- Type 3 - Postoperative atelectasis (subset of Type 1/2, but classified separately due to frequency)
- Type 4 - Respiratory failure secondary to shock, where metabolic demands exceed the respiratory system's capacity (e.g. sepsis, haemorrhage); intubation offloads the respiratory muscles and decreases O2 consumption
- Mixed - Coexisting hypoxaemia and hypercapnia from multiple concurrent processes (most common in clinical practice)
Sources: Tintinalli's Emergency Medicine, The Washington Manual of Medical Therapeutics, Creasy & Resnik's Maternal-Fetal Medicine
This is a shared conversation. Sign in to Orris to start your own chat.